Pediatric Obesity, published by WILEY, is a leading international journal dedicated to advancing research and practices in the prevention and management of pediatric obesity. With an impressive impact factor and recognized as a Q1 journal in categories including Health Policy, Nutrition and Dietetics, and Pediatrics, it provides a vital platform for scientists, healthcare professionals, and policymakers to disseminate findings that shape public health initiatives. The journal's commitment to open access facilitates broad dissemination of high-quality research, ensuring vital insights reach a global audience. Since its inception in 2012, Pediatric Obesity has consistently ranked among the top in its field, reflecting its critical role in addressing the growing epidemic of childhood obesity and influencing evidence-based strategies for healthier futures. Researchers and practitioners alike will find value in its rich assortment of articles, reviews, and case studies that foster an interdisciplinary approach to tackling this pressing health issue.

Schizophrenia Research is a premier academic journal focused on innovative research within the domain of psychiatry and mental health, published by Elsevier. With its ISSN 0920-9964 and E-ISSN 1573-2509, the journal has established a strong presence since its inception in 1988, evolving to publish cutting-edge findings up to 2024. Positioned in Q1 in Psychiatry and Mental Health and Q2 in Biological Psychiatry, it ranks impressively in the 83rd percentile among its peers, according to Scopus, ranking #93/567 in the field of Medicine, and #12/51 in Neuroscience. This journal serves as a vital platform for the dissemination of significant scientific advancements and theoretical insights into schizophrenia, fostering a deeper understanding of mental illnesses. Although it operates on a subscription basis, its critical role in informing both ongoing research and clinical practices cannot be overstated, making it an essential resource for researchers, clinicians, and students alike. Join a global community dedicated to improving mental health outcomes and advancing the study of schizophrenia through this reputable publication.

Eating and Weight Disorders-Studies on Anorexia Bulimia and Obesity, published by SPRINGER, is a pivotal journal in the fields of Clinical Psychology and Psychiatry that addresses the multifaceted issues surrounding eating disorders, including anorexia, bulimia, and obesity. With an impressive impact factor reflecting its commitment to quality research, this journal is ranked in the Q2 quartile for both Clinical Psychology and Psychiatry and Mental Health. The journal has transitioned to an Open Access model as of 2023, broadening its reach and facilitating greater access to vital research findings in the areas of eating behaviors and weight management. Operating from its base in Switzerland, Eating and Weight Disorders serves as an essential resource for researchers, clinicians, and students alike, presenting high-quality empirical studies, reviews, and case reports that contribute significantly to the understanding of these complex conditions. With a rich publication history dating back to 1998, the journal continues to maintain its relevance in the ongoing discourse surrounding mental health and weight issues on a global scale.

ACTA NEUROPSYCHIATRICA is a distinguished journal published by Cambridge University Press, covering essential research across the fields of psychiatry and neuroscience. Since its inception in 1989, it has become a pivotal resource for researchers and clinicians, providing a platform for the latest advancements and insights in biological psychiatry. With an impressive Scopus rank of #66 out of 567 in the Psychiatry and Mental Health category, and #10 out of 51 in Biological Psychiatry, the journal is recognized for its significant contributions to the field, boasting an 88th percentile ranking in overall impact. Although it operates under a traditional access model, the journal remains committed to disseminating high-quality research that addresses critical issues in mental health. Whether you are a professional seeking the latest findings or a student aiming to deepen your knowledge, ACTA NEUROPSYCHIATRICA is an indispensable resource for cutting-edge developments that shape our understanding of the human mind.

The International Journal of Mental Health and Addiction, published by Springer, stands as a premier resource within the field of psychiatry and mental health. With an impressive impact factor placing it in the Q1 category and ranking #17 out of 567 journals in its discipline according to Scopus, this journal plays a crucial role in advancing scholarly research and practices related to mental health and addiction. Since its inception in 2006, the journal has committed to disseminating high-quality, peer-reviewed work that addresses contemporary challenges in mental health, including innovative treatment strategies, policy implications, and psychosocial dynamics. Operating from New York, USA, the journal also aims to foster interdisciplinary collaboration, providing a platform for researchers, clinicians, and policymakers. While it does not offer open access, the publication is dedicated to making impactful research accessible to its audience by ensuring that content is widely disseminated. The International Journal of Mental Health and Addiction, with its rigorous editorial standards and dedication to mental health advancement, remains an essential journal for anyone pursuing knowledge in the ever-evolving landscape of mental health and addiction.

Current Opinion in Psychiatry is a premier journal published by Lippincott Williams & Wilkins, dedicated to the dynamic and evolving field of psychiatry and mental health. With a commendable impact factor and ranking 30th out of 567 in the Scopus database, this journal occupies a Q1 quartile position, reflecting its significance and influence within the academic community. Since its inception in 1988, Current Opinion in Psychiatry has aimed to provide critical reviews, leading research, and expert opinions that shape clinical practice and decision-making in psychiatry. While the journal is not open access, it continues to serve as an essential resource for researchers, clinicians, and students seeking insights into contemporary psychiatric challenges and advancements. With its ongoing commitment to high-quality content, the journal remains a vital platform for knowledge dissemination and dialog in the field.

Obesity Research & Clinical Practice is an esteemed journal published by ELSEVIER SCI LTD, focusing on cutting-edge research and clinical practices related to obesity and its multifaceted impact on health and wellness. With an ISSN of 1871-403X and an E-ISSN of 1878-0318, this journal serves as a vital resource for researchers and practitioners in the fields of Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. Notably, it holds a Q2 ranking in Endocrinology, Diabetes and Metabolism and a prestigious Q1 ranking in Nutrition and Dietetics for 2023, reflecting its influence and quality within the scientific community. The journal features a broad scope of research topics encompassing clinical findings, epidemiological studies, and therapeutic advancements in obesity treatment, aiming to improve health outcomes globally. Submissions are encouraged from diverse disciplines, ensuring a dynamic and multidisciplinary approach to tackling obesity-related challenges. Given its convergence of years from 2007 to 2024, Obesity Research & Clinical Practice stands as a prominent platform for disseminating valuable knowledge, insights, and groundbreaking research in this pressing area of public health.

The JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, published by AMER PSYCHIATRIC PUBLISHING, INC, stands as a pivotal resource in the interdisciplinary fields of psychiatry, neurology, and mental health. With a history spanning from 1989 to 2024, this esteemed journal, identified by the ISSN 0895-0172 and E-ISSN 1545-7222, provides a platform for cutting-edge research and clinical insights into neuropsychiatric disorders. As of 2023, the journal is recognized in Q2 quartiles for Medicine (miscellaneous), Neurology (clinical), and Psychiatry and Mental Health, showcasing its significant impact within these domains, as evidenced by its Scopus rankings placing it in the 67th and 65th percentiles respectively. The journal emphasizes the importance of advancing knowledge through empirical studies, case reports, and reviews, making it an invaluable asset for researchers, clinicians, and students dedicated to understanding the complexities of the human brain and its psychological manifestations. Although the journal does not currently offer open access, it remains essential for those seeking to stay at the forefront of neuropsychiatric advancements.

Clinical Obesity, published by WILEY, is a leading journal in the field of Endocrinology, Diabetes, and Metabolism that strives to advance the understanding of obesity-related health issues. With an ISSN of 1758-8103 and an E-ISSN of 1758-8111, this journal provides a platform for cutting-edge research and findings pertaining to the epidemiology, pathophysiology, prevention, and treatment of obesity. Recognized with a Q2 ranking in both Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous) categories, and boasting a Scopus rank of #90 out of 244, Clinical Obesity encompasses innovative studies that influence clinical practice and public health policies. While this journal operates under a subscription model, its discipline-specific contributions are invaluable for researchers, healthcare professionals, and students keen on addressing the complexities of obesity in a comprehensive manner.

EATING DISORDERS, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing the understanding of eating disorders from diverse psychological, medical, and social perspectives. With an ISSN of 1064-0266 and an E-ISSN of 1532-530X, this journal is recognized for its rigorous peer-reviewed research and innovative studies, contributing significantly to the field of clinical psychology and psychiatry. It boasts impressive rankings, including a Q1 classification in Clinical Psychology and a Q1 classification in Medicine (miscellaneous) based on the 2023 category quartiles. Researchers will find its impactful insights invaluable, as it ranks 31st out of 311 in clinical psychology, placing it in the top 10% percentile. Although this journal is not open access, it encompasses a comprehensive range of topics related to eating disorders, fostering a deeper understanding that benefits practitioners, researchers, and students alike. For those dedicated to addressing the complexities of eating disorders, EATING DISORDERS is an essential resource that bridges the gap between research and real-world application.